Whole exome sequencing in the diagnostic workup of patients with a bleeding diathesis
Authors:
- 15 November 2018
- journal article
- research article
- Published by Wiley in Haemophilia
- Vol. 25 (1) , 127-135
Abstract
Introduction: Bleeding assessment tools and laboratory phenotyping often remain inconclusive in patients with a haemorrhagic diathesis.Aim: To describe the phenotype and genetic profile of patients with a bleeding tendency.Methods: Whole exome sequencing (WES) was incorporated in the routine diagnostic pathway of patients with thrombocytopenia (n = 17), platelet function disorders (n = 19) and an unexplained bleeding tendency (n = 51). The analysis of a panel of 126 OMIM (Online Mendelian Inheritance in Man) genes involved in thrombosis and haemostasis was conducted, and if negative, further exome‐wide analysis was performed if informed consent given.Results: Eighteen variants were detected in 15 patients from a total of 87 patients (17%). Causative variants were observed in MYH9 (two cases), SLFN14, P2RY12 and GP9. In addition, one case was considered solved due to combined carriership of F7 and F13A1 variants and one with combined carriership of F2, F8 and VWF, all variants related to secondary haemostasis protein aberrations. Two variants of uncertain significance (VUS) were found in two primary haemostasis genes: GFI1B and VWF. Eight patients were carriers of autosomal recessive disorders. Exome‐wide analysis was performed in 54 cases and identified three variants in candidate genes.Conclusion: Based on our findings, we conclude that performing WES at the end of the diagnostic trajectory can be of additive value to explain the complete bleeding phenotype in patients without a definite diagnosis after conventional laboratory tests. Discovery of combinations of (novel) genes that predispose to bleeding will increase the diagnostic yield in patients with an unexplained bleeding diathesis.Keywords
This publication has 84 references indexed in Scilit:
- First Successful Use of Eltrombopag Before Surgery in a Child With MYH9-Related ThrombocytopeniaPediatrics, 2013
- Impact of sex, age, race, ethnicity and aspirin use on bleeding symptoms in healthy adultsJournal of Thrombosis and Haemostasis, 2010
- The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing dataGenome Research, 2010
- Fast and accurate long-read alignment with Burrows–Wheeler transformBioinformatics, 2010
- Combined homology modelling and evolutionary significance evaluation of missense mutations in blood clotting factor VIII to highlight aspects of structure and functionHaemophilia, 2009
- Factor V C2 domain contains a major thrombin‐binding site responsible for thrombin‐catalyzed factor V activationJournal of Thrombosis and Haemostasis, 2006
- γAla82Gly represents a common fibrinogen γ-chain variant in CaucasiansBlood Coagulation & Fibrinolysis, 2005
- The Phosphatidylserine Binding Site of the Factor Va C2 Domain Accounts for Membrane Binding but Does Not Contribute to the Assembly or Activity of a Human Factor Xa−Factor Va ComplexBiochemistry, 2004
- Platelet proteomicsJournal of Thrombosis and Haemostasis, 2003
- Topologically equivalent mutations causing dysfunctional coagulation factors VII (294Ala→Val) and X (334Ser→ Pro)Human Molecular Genetics, 1994